ȸ»ç°³¿ä |
´ë±×·ì°è¿Á¦¾à¹ÙÀÌ¿Àȸ»ç |
¸ðÁýÁ¦¸ñ |
»ç¾÷°³¹ß |
±Ù¹«Áö¿ª |
°æ±âµµ |
Á¦Ãâ¼·ù |
À̷¼, °æ·Â±â¼ú¼, »çÁøÆÄÀÏ÷ºÎ(±¹¹®) |
Àüü°æ·Â |
3³â
~ 10³â |
³ªÀÌ |
Á¦ÇѾøÀ½
|
ÇзÂ/Àü°ø |
´ëÇб³(4³â) Á¹¾÷ ÀÌ»ó |
¿Ü±¹¾î1 |
¿µ¾î / ºñÁö´Ï½º Ä¿¹Â´ÏÄÉÀÌ¼Ç |
¸ðÁý³»¿ë |
¡Ø Á÷¹«°³¿ä
½Å¾à°³¹ß/Á¦¾à»ç¾÷ÀÇ »ç¾÷°³¹ß ¾÷¹« (Licensing In ¾÷¹«)
- SKBP Portfolio °È¸¦ À§ÇÑ »ç¾÷ °³¹ß Àü·« ¼ö¸³ ¹× ÃßÁø
- Global Partnering (L/I, Co-Dev & Co-P, J/V Æ÷ÇÔ Open InnovationÀÇ ´Ù¾çÇÑ °è¾à ±¸Á¶
Global Deal ü°á)
- Pipeline Evaluation : Licensing In ¼öÇàÀ» À§ÇÑ Pipeline/Product Æò°¡
(ÀÓ»ó/ÀüÀÓ»ó data Çؼ® ¹× ºÐ¼®) ¹× Key Opinion Leader ÀÎÅͺä
- Global/Regional Market Analysis / Product Commercial Analysis
- ½Å¾à°³¹ß BusinessÀÇ Àü¹ÝÀûÀÎ »ç¾÷°³¹ß¾÷¹« ¼öÇà
¡Ø ÀÚ°ÝÁ¶°Ç
- »ý¸í°úÇÐ, ÈÇÐ, ¾àÇеî Life Science Àü°øÀÚ - CNS ¹× Oncology ¿¬±¸°³¹ßÀ¯°æÇèÀÚ¹× MBA ¿ì´ë
- ¾÷¹«°æ·Â: Global Licensing In/Out ¾÷¹«¼öÇà °æÇè, Commercial Analysis, »ç¾÷°³¹ß À¯°ü¾÷¹«°æÇèÀÚ
(ƯÈ÷ °¡Ä¡Æò°¡ ¼öÇà ´É·Â ¹× Market & Product Commercial Analysis ´É·Â Çʼö)
- °úÀå±Þ BD ¾÷¹«°æ·Â 5³âÀÌ»ó / ´ë¸®±Þ BD ¾÷¹«°æ·Â 3³âÀÌ»ó
- Very Fluent in Business English: Çù»ó¹× KoL ÀÎÅͺ䰡´É¼öÁØÀÇ¿µ¾î
(*¼±¹ß½Ã¿µ¾î¸éÁ¢¹×¿µ¾î Presentation Çʼö)
- Good Communication skill
- ÇØ¿ÜÃâÀå°¡´É
- ¿¢¼¿/ ¿öµå/ ÆÄ¿öÆ÷ÀÎÆ®Çʼö
|
±âŸÁ¤º¸ |
|
|